SCHEMBL17853549

SCHEMBL17853549

c1ccc(-c2nc(-c3ccc(-c4ccncc4)cc3)cc(-c3ccc(-n4c5ccccc5c5cc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)ccc54)cc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.43
▸ ATM Q13315 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ MAPT P10636 8/20 0.41
▸ KMT2A Q03164 7/20 0.41
▸ MEN1 O00255 5/20 0.41
▸ DHODH Q02127 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.40
▸ HPGD P15428 3/20 0.40
▸ NTSR1 P30989 1/20 0.40
▸ NPSR1 Q6W5P4 3/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17853526 0.99 KDM4E (0.44) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL23085190 0.98 KDM4E (0.45) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL17853517 0.96 KDM4E (0.44) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL19486679 0.95 KDM4E (0.41) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL14416402 0.95 KMT2A (0.44) KDM4EMAPTKMT2AMEN1DHODH
SCHEMBL6374795 0.94 KDM4E (0.49) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL19397645 0.94 MAPT (0.45) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL6373259 0.94 KDM4E (0.49) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL6375032 0.94 KDM4E (0.49) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL17853562 0.94 MAPT (0.45) KDM4EATML3MBTL1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, PIEZO1, SLC39A11 KDM4E 2180/4885ATM 3426/4885L3MBTL1 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback